Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$5.8K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Jun 26 | PCSA | Processa Pharmaceuticals,… | MEXER | 203 | — | — | +8.7% | Open the original filing on SEC.gov |
| Mar 31 | PCSA | Processa Pharmaceuticals,… | PBUY | 2,269 | $2.54 | $5.8K | +4,052% | Open the original filing on SEC.gov |
| Oct 1, 2025 | PCSA | Processa Pharmaceuticals,… | AGRANT◆ | 300,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 1, 2025 | PCSA | Processa Pharmaceuticals,… | AGRANT◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 11, 2025 | LGVN | Longeveron Inc. | PDBUY◆ | 29,415 | — | — | — | Open the original filing on SEC.gov |
| Aug 11, 2025 | LGVN | Longeveron Inc. | PBUY | 11,766 | — | — | +28.9% | Open the original filing on SEC.gov |
| Jul 15, 2025 | LGVN | Longeveron Inc. | AGRANT | 17,000 | — | — | +71.6% | Open the original filing on SEC.gov |
| Sep 3, 2024 | PCSA | Processa Pharmaceuticals,… | AGRANT◆↺ | 31,206 | — | — | — | Open the original filing on SEC.gov |